HOME >> BIOLOGY >> NEWS
Cooperation to create a new tuberculosis vaccine

This release is also available in German

A cooperation agreement to initiate the development of a new type of preventive DNA subunit vaccine against tuberculosis (TB) has been signed by the Max Planck Institute for Infection Biology (MPI-IB) and MOLOGEN AG in Berlin. Subunit vaccines are composed of defined molecular immunogenic modules. Under its director Prof. Dr. Stefan H. E. Kaufmann, the Department of Immunology at the MPI-IB is studying the mechanisms of host - pathogen interactions and develops novel vaccination strategies; it is amongst the leading groups in Tuberculosis immunology research world wide. MOLOGEN focuses on proprietary DNA technologies to develop treatments for non- or inadequately treatable diseases.

With more than 2 million deaths and 9 million new infections annually, TB, along with malaria and HIV/AIDS, is responsible for the greatest number of infectious disease victims world wide. Of particular concern is the increasing number of pathogens resistant to conventional medication. The World Health Organisation estimates that some 50 million people around the globe are already infected with such multi-resistant strains. As the current TB vaccine BCG fails to protect against the most common form of the disease, pulmonary TB in adults, the need for an efficacious tuberculosis vaccine is more urgent than ever.

"The only prevention of TB is the viable BCG vaccine (Bacillus-Calmette-Guérin), which has been in use since 1921," says MPI-IB director Prof. Stefan H.E. Kaufmann. "BCG has a proven safety record for many decades, however, it unfortunately lacks effectiveness," notes Kaufmann, adding that only children can be protected against certain forms of TB by BCG. "however, BCG does not protect against pulmonary TB in adults at all. We assume the protection provided by BCG to be so limited because BCG bacteria fail to induce the compl
'"/>

Contact: Dr. Sabine Englich
englich@mpiib-berlin.mpg.de
49-302-846-0142
Max-Planck-Gesellschaft
8-Oct-2004


Page: 1 2 3

Related biology news :

1. 2006 AAAS International Scientific Cooperation Award goes to Arizona State U. landscape ecologist
2. Cooperation is keya new way of looking at MicroRNA and how it controls gene expression
3. Newly created cancer stem cells could aid breast cancer research
4. MIT creates 3-D images of living cell
5. Not all embryonic stem cell lines are created equal
6. Researchers use adult stem cells to create soft tissue
7. Fusing imaging technologies creates synergy, helps diagnose heart disease accurately
8. Researchers create model of cancer-preventing enzyme, study how it works
9. Researchers create interactive map with Google technology to track avian flu spread
10. Cancer scientists create human leukemia process to map how disease begins, progresses
11. Early-stage sperm cells created from human bone marrow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
Breaking Biology Technology:
Cached News: